The Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett
Year: 2014
Type: article
Abstract: The ways we have developed, used, and protected antibiotics have led, predictably, to our current crisis of rising antibiotic resistance and declining new treatments. If we want to stave off a postantibiotic era, we need to fundamentally change our approach. We need to challenge long-standing assumptions and cherished beliefs. We need to push through the reflexive resistance and excuses (eg, "that's not how we do things" and "that can't be done") that result from challenging established ways. Excuses abound. Action is needed. Ultimately, we need a coordinated national action plan to combat resistance. Herein we discuss 7 tasks and 3 common themes that cut across those tasks, which are necessary to achieve long-term success in dealing with antibiotics and resistance. These principles derive from many years of dialogue with Dr John Bartlett. The field of infectious diseases, and indeed medicine in general, has benefited immeasurably from his remarkable leadership.
Source: Clinical Infectious Diseases
DOI: 10.1093/cid/ciu392
Authors: B. Spellberg, D. N. Gilbert
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: Humanized Monoclonal Antibody to Treat Acinetobacter Infections, Antibody Targeting of KPC and NDM1, Acinetobacter virulence and host innunopathogenesis, Humanized Monoclonal Antibodies to Treat Acinetobacter Infections, A New Approach to Staphylococcus aureus Vaccine Development - Resubmission 01, Activated Targeted Killer (ATAK) Cells for Invasive Fungal Infections, Antibacterial Resistance Leadership Group (ARLG)
OpenAlex ID: W2043000592
